Jammu: The Indian Pharmacopoeia Commission held a scientific conclave on Indian Pharmacopoeia 2026 in Jammu to advance drug standards and ensure medicine quality.
The Commission organised the event with the Council of Scientific and Industrial Research at CSIR-Indian Institute of Integrative Medicine on April 17, 2026. The conclave brought together regulators, academicians, and industry experts to discuss key updates in pharmaceutical standards.
Senior officials addressed the inaugural session and stressed the need to strengthen drug quality frameworks. They said the Indian Pharmacopoeia 2026 serves as a critical tool to maintain uniform standards for medicines across the country. They also highlighted the need to align standards with evolving scientific and regulatory requirements.
Experts discussed revisions in monographs and improvements in impurity standards. They also examined modern analytical methods to enhance drug testing systems. In addition, participants reviewed regulatory perspectives and the need to upgrade microbiological and blood-related standards.
Indian Pharmacopoeia 2026 updates focus on drug quality
The sessions also covered standardisation of phytopharmaceuticals and strengthening quality control systems. Experts said these updates would help improve the safety and efficacy of medicines. Moreover, they stressed the importance of adopting global best practices in pharmacopoeial standards.
During the interactive session, stakeholders exchanged views on implementation challenges. They discussed industry preparedness and the need for coordination among regulators and manufacturers. Participants said collaboration remains key to ensuring effective adoption of Indian Pharmacopoeia 2026.
They also highlighted the role of scientific institutions in supporting regulatory frameworks. Experts noted that updated standards would help improve public trust in medicines. They added that continuous revision of pharmacopoeial norms remains essential for healthcare systems.
The conclave reaffirmed the Commission’s commitment to upgrading standards through scientific advances. Officials said such efforts would strengthen public health safeguards and ensure consistent medicine quality across India.
